These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Diurnal and circannual variation in platelet 3H-imipramine binding: comparative data on normal and affectively ill subjects. Baron M; Barkai A; Kowalik S; Fieve RR; Quitkin F; Gruen R Neuropsychobiology; 1988; 19(1):9-11. PubMed ID: 2847077 [TBL] [Abstract][Full Text] [Related]
29. Alteration of platelet [3H]imipramine binding in mildly depressed patients correlates with disease severity. Tanimoto K; Maeda K; Terada T Biol Psychiatry; 1985 Mar; 20(3):340-3. PubMed ID: 2983789 [No Abstract] [Full Text] [Related]
30. Unaltered platelet [3H]-imipramine binding in dementia of the Alzheimer type. Weizman R; Dick J; Mosek A; Tyano S; Rehavi M Neuropsychobiology; 1988; 19(2):69-72. PubMed ID: 2852311 [TBL] [Abstract][Full Text] [Related]
31. Platelet 3H-imipramine binding distinguishes depression from Alzheimer dementia. Suranyi-Cadotte BE; Gauthier S; Lafaille F; DeFlores S; Dam TV; Nair NP; Quirion R Life Sci; 1985 Dec; 37(24):2305-11. PubMed ID: 2999549 [TBL] [Abstract][Full Text] [Related]
32. Marked reduction in the number of platelet-tritiated imipramine binding sites in geriatric depression. Nemeroff CB; Knight DL; Krishnan RR; Slotkin TA; Bissette G; Melville ML; Blazer DG Arch Gen Psychiatry; 1988 Oct; 45(10):919-23. PubMed ID: 2844132 [TBL] [Abstract][Full Text] [Related]
33. Effect of phototherapy on 3H-imipramine binding sites in patients with SAD, non-SAD and in healthy controls. Szádóczky E; Falus A; Németh A; Teszéri G; Moussong-Kovács E J Affect Disord; 1991 Aug; 22(4):179-84. PubMed ID: 1658102 [TBL] [Abstract][Full Text] [Related]
34. Differential 3H-imipramine platelet binding in patients with panic disorder and depression. Innis RB; Charney DS; Heninger GR Psychiatry Res; 1987 May; 21(1):33-41. PubMed ID: 3037580 [TBL] [Abstract][Full Text] [Related]
35. Electroconvulsive shock therapy and maximum binding of platelet tritiated imipramine binding in depression. Langer SZ; Sechter D; Loo H; Raisman R; Zarifian E Arch Gen Psychiatry; 1986 Oct; 43(10):949-52. PubMed ID: 3019267 [TBL] [Abstract][Full Text] [Related]
36. 3H-Imipramine binding sites in platelets of hospitalized psychiatric patients. Gentsch C; Lichtsteiner M; Gastpar M; Gastpar G; Feer H Psychiatry Res; 1985 Mar; 14(3):177-87. PubMed ID: 2988002 [TBL] [Abstract][Full Text] [Related]
37. Changes in platelet 3H-imipramine binding with chronic imipramine treatment are not state-dependent. DeMet EM; Gerner RH; Bell KM; Kauffmann CD; Chicz-DeMet A; Warren S Biol Psychiatry; 1989 Sep; 26(5):478-88. PubMed ID: 2551399 [TBL] [Abstract][Full Text] [Related]
39. WHO pilot study on the validity of imipramine platelet receptor binding sites as a biological marker of endogenous depression. A preliminary report on the initial evaluation phase of a World Health Organization Collaborative Study. Bech P; Eplov L; Gastpar M; Gentsch C; Mendlewicz J; Plenge P; Rielaert C; Mellerup ET Pharmacopsychiatry; 1988 May; 21(3):147-50. PubMed ID: 2841696 [No Abstract] [Full Text] [Related]
40. Phototherapy increases platelet 3H-imipramine binding in patients with winter depression. Szádóczky E; Falus A; Arató M; Németh A; Teszéri G; Moussong-Kovács E J Affect Disord; 1989; 16(2-3):121-5. PubMed ID: 2537860 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]